Payment overview · 2025
General Payments
$25.25
1 reported records · 1 companies
Healthcare provider profile · identity verified
John Pylman, M.D.
Allopathic & Osteopathic Physicians|Hospitalist · UTICA, NY · NPI 1053560805
Verified facts
What the public records show
CMS Open Payments records show John Pylman, M.D. received $25.25 in general payments during 2025 across 1 reported records.
Indivior Inc. accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Indivior Inc. | Unresolved — no canonical attribution shown | $25.25 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $25.25 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| SUBLOCADE Normalized: sublocade |
Drug | Indivior Inc. | $25.25 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Eliquis | Apixaban | 380 | 48 |
| Levothyroxine Sodium | Levothyroxine Sodium | 316 | 58 |
| Sertraline Hcl | Sertraline Hcl | 278 | 43 |
| Furosemide | Furosemide | 244 | 54 |
| Gabapentin | Gabapentin | 240 | 53 |
| Mirtazapine | Mirtazapine | 212 | 40 |
| Atorvastatin Calcium | Atorvastatin Calcium | 210 | 48 |
| Pantoprazole Sodium | Pantoprazole Sodium | 206 | 54 |
| Trazodone Hcl | Trazodone Hcl | 152 | 25 |
| Amlodipine Besylate | Amlodipine Besylate | 145 | 38 |
| Levetiracetam | Levetiracetam | 145 | 17 |
| Quetiapine Fumarate | Quetiapine Fumarate | 143 | 26 |
| Baclofen | Baclofen | 132 | 25 |
| Omeprazole | Omeprazole | 120 | 23 |
| Potassium Chloride | Potassium Chloride | 113 | 32 |
| Warfarin Sodium | Warfarin Sodium | 109 | 11 |
| Tamsulosin Hcl | Tamsulosin Hcl | 104 | 28 |
| Lisinopril | Lisinopril | 103 | 19 |
| Nystatin | Nystatin | 99 | 49 |
| Divalproex Sodium | Divalproex Sodium | 98 | 18 |
| Memantine Hcl | Memantine Hcl | 97 | 17 |
| Losartan Potassium | Losartan Potassium | 94 | 26 |
| Metoprolol Tartrate | Metoprolol Tartrate | 94 | 33 |
| Torsemide | Torsemide | 92 | 33 |
| Clonazepam | Clonazepam | 91 | 25 |
| Escitalopram Oxalate | Escitalopram Oxalate | 89 | 19 |
| Famotidine | Famotidine | 87 | 15 |
| Metformin Hcl | Metformin Hcl | 87 | 19 |
| Tradjenta | Linagliptin | 87 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 86 | suppressed |
| Myrbetriq | Mirabegron | 86 | 13 |
| Simvastatin | Simvastatin | 83 | 15 |
| Xarelto | Rivaroxaban | 81 | 15 |
| Risperidone | Risperidone | 80 | suppressed |
| Klor-Con M10 | Potassium Chloride | 74 | 18 |
| Lorazepam | Lorazepam | 72 | 40 |
| Metoprolol Succinate | Metoprolol Succinate | 72 | 18 |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 68 | 37 |
| Jardiance | Empagliflozin | 67 | suppressed |
| Olanzapine | Olanzapine | 67 | 12 |
| Allopurinol | Allopurinol | 66 | 12 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 66 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 65 | 12 |
| Citalopram Hbr | Citalopram Hydrobromide | 64 | 11 |
| Montelukast Sodium | Montelukast Sodium | 64 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 62 | 42 |
| Clopidogrel | Clopidogrel Bisulfate | 59 | 18 |
| Buspirone Hcl | Buspirone Hcl | 57 | 12 |
| Hydralazine Hcl | Hydralazine Hcl | 54 | 20 |
| Arexvy | Rsvpref3 Antigen/As01e/Pf | 53 | 49 |
| Metoclopramide Hcl | Metoclopramide Hcl | 53 | 11 |
| Trintellix | Vortioxetine Hydrobromide | 53 | suppressed |
| Januvia | Sitagliptin Phosphate | 52 | suppressed |
| Finasteride | Finasteride | 51 | suppressed |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 47 | 23 |
| Lactulose | Lactulose | 47 | 17 |
| Latanoprost | Latanoprost | 46 | 11 |
| Erythromycin | Erythromycin Base | 45 | 16 |
| Fluticasone Propionate | Fluticasone Propionate | 45 | 12 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 44 | suppressed |
| Spironolactone | Spironolactone | 44 | suppressed |
| Sucralfate | Sucralfate | 44 | suppressed |
| Azithromycin | Azithromycin | 41 | 21 |
| Morphine Sulfate | Morphine Sulfate | 41 | 29 |
| Ondansetron Hcl | Ondansetron Hcl | 41 | 26 |
| Tramadol Hcl | Tramadol Hcl | 41 | 18 |
| Duloxetine Hcl | Duloxetine Hcl | 38 | suppressed |
| Atropine Sulfate | Atropine Sulfate | 37 | suppressed |
| Carvedilol | Carvedilol | 37 | 15 |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 37 | 14 |
| Phenobarbital | Phenobarbital | 37 | suppressed |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 36 | suppressed |
| Donepezil Hcl | Donepezil Hcl | 36 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 36 | 15 |
| Cefpodoxime Proxetil | Cefpodoxime Proxetil | 35 | 26 |
| Glycopyrrolate | Glycopyrrolate | 35 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 35 | suppressed |
| Naltrexone Hcl | Naltrexone Hcl | 35 | suppressed |
| Pravastatin Sodium | Pravastatin Sodium | 35 | 12 |
| Cephalexin | Cephalexin | 33 | 27 |
| Clonidine Hcl | Clonidine Hcl | 33 | suppressed |
| Lamotrigine | Lamotrigine | 32 | suppressed |
| Methenamine Hippurate | Methenamine Hippurate | 32 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 32 | suppressed |
| Linzess | Linaclotide | 31 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 31 | suppressed |
| Alprazolam | Alprazolam | 30 | suppressed |
| Haloperidol | Haloperidol | 30 | suppressed |
| Atenolol | Atenolol | 29 | suppressed |
| Constulose | Lactulose | 29 | suppressed |
| Lacosamide | Lacosamide | 29 | suppressed |
| Phenytoin | Phenytoin | 29 | suppressed |
| Rexulti | Brexpiprazole | 29 | suppressed |
| Colestipol Hcl | Colestipol Hcl | 28 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 28 | 15 |
| Scopolamine | Scopolamine | 27 | 12 |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 27 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 26 | suppressed |
| Entresto | Sacubitril/Valsartan | 26 | suppressed |
| Albuterol Sulfate | Albuterol Sulfate | 25 | suppressed |
| Carbidopa-Levodopa Er | Carbidopa/Levodopa | 25 | suppressed |
| Dulera | Mometasone/Formoterol | 25 | suppressed |
| Dexamethasone Sodium Phosphate | Dexamethasone Sodium Phosphate | 24 | suppressed |
| Prednisone | Prednisone | 24 | 16 |
| Budesonide | Budesonide | 22 | suppressed |
| Ceftriaxone | Ceftriaxone Sodium | 22 | suppressed |
| Meloxicam | Meloxicam | 22 | suppressed |
| Nuedexta | Dextromethorphan Hbr/Quinidine | 22 | suppressed |
| Topiramate | Topiramate | 22 | suppressed |
| Multaq | Dronedarone Hcl | 21 | suppressed |
| Fentanyl | Fentanyl | 20 | 11 |
| Ranolazine Er | Ranolazine | 20 | suppressed |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 20 | suppressed |
| Bupropion Xl | Bupropion Hcl | 19 | suppressed |
| Colchicine | Colchicine | 19 | suppressed |
| Hydrocortisone | Hydrocortisone | 19 | 11 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 19 | suppressed |
| Trimethoprim | Trimethoprim | 19 | suppressed |
| Aripiprazole | Aripiprazole | 18 | suppressed |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 18 | suppressed |
| Amantadine | Amantadine Hcl | 17 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 17 | suppressed |
| Diltiazem 24hr Er (La) | Diltiazem Hcl | 17 | suppressed |
| Donepezil Hcl Odt | Donepezil Hcl | 17 | suppressed |
| Prednisolone Acetate | Prednisolone Acetate | 17 | suppressed |
| Pyridostigmine Bromide | Pyridostigmine Bromide | 17 | suppressed |
| Telmisartan | Telmisartan | 17 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 17 | suppressed |
| Trulicity | Dulaglutide | 17 | suppressed |
| Clonidine | Clonidine | 16 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 16 | 14 |
| Cyclosporine | Cyclosporine | 16 | suppressed |
| Metolazone | Metolazone | 16 | suppressed |
| Nuplazid | Pimavanserin Tartrate | 16 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 15 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 15 | suppressed |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 15 | suppressed |
| Levofloxacin | Levofloxacin | 15 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 15 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 15 | suppressed |
| Santyl | Collagenase Clostridium Hist. | 15 | 12 |
| Zenpep | Lipase/Protease/Amylase | 15 | suppressed |
| Zonisamide | Zonisamide | 15 | suppressed |
| Cimetidine | Cimetidine | 14 | suppressed |
| Glatopa | Glatiramer Acetate | 14 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 14 | suppressed |
| Metronidazole | Metronidazole | 14 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 14 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 14 | suppressed |
| Tetrabenazine | Tetrabenazine | 14 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 14 | suppressed |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 13 | suppressed |
| Diazepam | Diazepam | 13 | suppressed |
| Digoxin | Digoxin | 13 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 13 | suppressed |
| Layolis Fe | Noreth-Ethinyl Estradiol/Iron | 13 | suppressed |
| Lidocaine Hcl | Lidocaine Hcl | 13 | suppressed |
| Lumigan | Bimatoprost | 13 | suppressed |
| Methimazole | Methimazole | 13 | suppressed |
| Novolog Flexpen | Insulin Aspart | 13 | suppressed |
| Pentoxifylline | Pentoxifylline | 13 | suppressed |
| Perphenazine | Perphenazine | 13 | suppressed |
| Sps | Sodium Polystyrene Sulfon/Sorb | 13 | 12 |
| Timolol Maleate | Timolol Maleate | 13 | suppressed |
| Acetazolamide Er | Acetazolamide | 12 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 12 | suppressed |
| Bethanechol Chloride | Bethanechol Chloride | 12 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 12 | suppressed |
| Incruse Ellipta | Umeclidinium Bromide | 12 | suppressed |
| Ketoconazole | Ketoconazole | 12 | suppressed |
| Memantine Hcl Er | Memantine Hcl | 12 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 12 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 12 | suppressed |
| Tranexamic Acid | Tranexamic Acid | 12 | suppressed |
| Hydroxyurea | Hydroxyurea | 11 | suppressed |
| Ibuprofen | Ibuprofen | 11 | suppressed |
| Lubiprostone | Lubiprostone | 11 | suppressed |
| Nifedipine Er | Nifedipine | 11 | suppressed |
| Xcopri | Cenobamate | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $25.25 · 1 records | Indivior Inc. | SUBLOCADE | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error